GHRELIN-ANALOGA

European patent · EP1578778 · Deleted

Register entry

Publication number
EP1578778
Application number
EP03765930
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 23, 2003
Published
Sep 28, 2005
Granted
Jan 26, 2011
Deleted
Jul 31, 2018
Reason
Annual fee unpaid
IPC classes
C07K 14/60 (2006.01)
A61K 38/25 (2006.01)
Priority
US 397834 P 23.07.2002
US 427488 P 19.11.2002
PCT application
PCT/US2003/022925 23.07.2003
PCT publication
WO2004/009616 29.01.2004
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 20, 2019

    Deleted, fee unpaid

    Published in Swissreg on 20.02.2019

  2. Feb 9, 2011

    Agent entered

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 324, 1226 Geneve-Thônex

    Published in Swissreg on 09.02.2011

  3. Jan 26, 2011

    Granted

    Published in Swissreg on 26.01.2011

Parties

Holder

IPSEN PHARMA

65 Quai Georges Gorse, 92100 Boulogne-Billancourt, FR

Agent

Kirker & Cie SA

Kirker & Cie S.A.

122, rue de Genève Case postale 324, 1226 Geneve-Thônex

Inventor

DONG, Zheng, Xin

Holliston, MA 01746, US

SHEN, Yeelana

Franklin, MA 02038, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.